advertisement
11.4 Prostaglandins (16)
Showing records 1 to 16
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins23547 Ocular surface disfunction in glaucoma
Stefan C; Dumitrica DM
Oftalmologia 2008; 52: 114-119
23664 Latanoprost protects rat retinal ganglion cells from apoptosis in vitro and in vivo
Kanamori A; Naka M; Fukuda M; Nakamura M; Negi A
Experimental Eye Research 2009; 88: 535-541
23779 A randomised crossover study comparing bimatoprost and latanoprost in subjects with primary angle closure glaucoma
How AC; Kumar RS; Chen YM; Su DH; Gao H; Oen FT; Ho CL; Seah SK; Aung T
British Journal of Ophthalmology 2009; 93: 782-786
23908 Efficacy and safety of latanoprost in eyes with uveitic glaucoma
Markomichelakis NN; Kostakou A; Halkiadakis I; Chalkidou S; Papakonstantinou D; Georgopoulos G
Graefe's Archive for Clinical and Experimental Ophthalmology 2009; 247: 775-780
23750 Effect of unoprostone on topographic and blood flow changes in the ischemic optic nerve head of rabbits
Sugiyama T; Mashima Y; Yoshioka Y; Oku H; Ikeda T
Archives of Ophthalmology 2009; 127: 454-459
23517 The effect of prostaglandin analogs and prostamide on central corneal thickness
Hatanaka M; Vessani RM; Elias IR; Morita C; Susanna Jr R
Journal of Ocular Pharmacology and Therapeutics 2009; 25: 51-53
23817 Deepening of eyelid superior sulcus during topical travoprost treatment
Yang HK; Park KH; Kim TW; Kim DM
Japanese Journal of Ophthalmology 2009; 53: 176-179
23532 Travoprost in children: Adverse effects and intraocular pressure response
Yanovitch TL; Enyedi LB; Schotthoeffer EO; Freedman SF
Journal of AAPOS 2009; 13: 91-93
23514 Efficacy and tolerability of latanoprost compared to dorzolamide combined with timolol in the treatment of patients with elevated intraocular pressure: A meta-analysis of randomized, controlled trials
Cheng J-W; Xi G-L; Wei R-L; Cai J-P; Li Y
Journal of Ocular Pharmacology and Therapeutics 2009; 25: 55-64
23486 Herpetic keratitis in a patient who used two different prostaglandin analogue ophthalmic solutions: a case report
Villegas VM; Diaz L; Izquierdo NJ
Puerto Rico health sciences journal 2008; 27: 348-349
23572 Ocular hypotensive efficacy and safety of travoprost 0.004% in inadequately controlled primary open-angle glaucoma or ocular hypertension: short-term, multicenter, prospective study
Blini M; Rossi GC; Trabucchi G; Curatola MR; David A; Radaelli R; Merlo G; Ratiglia R
Current Medical Research and Opinion 2009; 25: 57-63
23916 Incidence of hyperemia associated with bimatoprost treatment in naïve subjects and in subjects previously treated with latanoprost
Kurtz S; Mann O
European Journal of Ophthalmology 2009; 19: 400-403
23942 Effects of prostanoid EP agonists on mouse intraocular pressure
Saeki T; Ota T; Aihara M; Araie M
Investigative Ophthalmology and Visual Science 2009; 50: 2201-2208
23707 Prostaglandin analogues in the anterior eye: their pressure lowering action and side effects
Cracknell KP; Grierson I
Experimental Eye Research 2009; 88: 786-791
23492 New prostaglandin derivative for glaucoma treatment
Perrino E; Uliva C; Lanzi C; Soldato PD; Masini E; Sparatore A
Bioorganic and Medicinal Chemistry Letters 2009; 19: 1639-1642
23833 Personality traits, depression, and objectively measured adherence to once-daily prostaglandin analog medication in glaucoma
Holló G; Kóthy P; Géczy A; Vargha P
Journal of Glaucoma 2009; 18: 288-292
